Proton Pump Inhibitors Inhibit Metformin Uptake by Organic Cation Transporters (OCTs)

Organic Cation Transporter 2 Mediates Cisplatin-Induced Oto- and Nephrotoxicity and Is a Target for Protective Interventions

(2010) Giuliano Ciarimboli et al.   AMERICAN JOURNAL OF PATHOLOGY

Protecting Cisplatin-Induced Nephrotoxicity with Cimetidine Does Not Affect Antitumor Activity

(2010) Hiromu Katsuda et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects

(2010) J. M. Moreno-Navarrete et al.   DIABETES

Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

(2010) Ligong Chen et al.   Pharmacogenetics and Genomics

Interaction of beta-blockers with the renal uptake transporter OCT2

(2009) I. Bachmakov et al.   DIABETES OBESITY & METABOLISM

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver

(2009) Anne T. Nies et al.   HEPATOLOGY

Epidemiology and clinical characteristics of GERD in the Japanese population

(2009) Yasuhiro Fujiwara et al.   JOURNAL OF GASTROENTEROLOGY

Transport of Lamivudine [(-)- -L-2',3'-Dideoxy-3'-thiacytidine] and High-Affinity Interaction of Nucleoside Reverse Transcriptase Inhibitors with Human Organic Cation Transporters 1, 2, and 3

(2009) G. Minuesa et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis

(2009) Kristian B. Filion et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus

(2009) M L Becker et al.   PHARMACOGENOMICS JOURNAL

Interaction of Oral Antidiabetic Drugs With Hepatic Uptake Transporters: Focus on Organic Anion Transporting Polypeptides and Organic Cation Transporter 1

(2008) I. Bachmakov et al.   DIABETES

Explaining the Decline in Early Mortality in Men and Women With Type 2 Diabetes: A population-based cohort study

(2008) J. Charlton et al.   DIABETES CARE

Structural Requirements for Drug Inhibition of the Liver Specific Human Organic Cation Transport Protein 1

(2008) Gustav Ahlin et al.   JOURNAL OF MEDICINAL CHEMISTRY

Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)

(2008) Oliver Zolk et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Therapy Insight: gastrointestinal complications of diabetes—pathophysiology and management

(2008) Joseph H Sellin et al.   Nature clinical practice. Gastroenterology & hepatology

Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1)

(2007) R Moaddel et al.   BRITISH JOURNAL OF PHARMACOLOGY